04/01/2025

NCCN Updates

Updated April 1, 2025

2025 Updates

April

• NCCN Guidelines Updated for Cervical Cancer 

March

• NCCN Guidelines and NCCN Templates Updated for Hepatocellular Carcinoma and Biliary Tract Cancers 
• NCCN Guidelines Updated for Adult Cancer Pain 
• NCCN Guidelines and NCCN Templates Updated for Gastric Cancer 
• NCCN Guidelines Updated for Cancer-Associated Venous Thromboembolic Disease 

February 

• NCCN Guidelines Updated for Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusions 
• NCCN Guidelines and NCCN Templates Updated for Melanoma: Uveal 
• NCCN Guidelines Updated for Pancreatic Adenocarcinoma 
• NCCN Guidelines Updated for Melanoma: Cutaneous 

January

• NCCN Guidelines Updated for Central Nervous System Cancers  
• NCCN Guidelines Updated for Thyroid Carcinoma 
• NCCN Guidelines Updated for Hepatocellular Carcinoma and Biliary Tract Cancers 
• NCCN Guidelines Updated for Hodgkin Lymphoma 

---

---

2024 Updates

December

• NCCN Guidelines Updated for Survivorship 
• NCCN Guidelines Updated for Head and Neck Cancers 

November

• NCCN Guidelines Updated for Mesothelioma: Pleural and Mesothelioma: Peritoneal 
• NCCN Guidelines Updated for Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate 
• NCCN Guidelines Updated for Kaposi Sarcoma 

October

• NCCN Templates Updated for Dermatofibrosarcoma Protuberans 
• NCCN Guidelines Updated for Hematopoietic Growth Factors 
• NCCN Guidelines Updated for Mesothelioma: Pleural and Peritoneal  
• NCCN Guidelines Updated for Adolescent and Young Adult Oncology 

September

• NCCN Guidelines Updated for Uterine Neoplasms 
• NCCN Guidelines Updated for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 
• NCCN Guidelines Updated for Small Cell Lung Cancer 
• NCCN Guidelines Updated for Pediatric Acute Lymphoblastic Leukemia 

August

• NCCN Guidelines Updated for Colon Cancer and Rectal Cancer 
• NCCN Guidelines Updated for Gastric Cancer 
• NCCN Guidelines Updated for Genetic/Familial High-Risk Assessment: Colorectal, Endometrial, and Gastric 
• NCCN Guidelines Updated for Esophageal and Esophagogastric Junction Cancers and More 

July

• NCCN Guidelines Updated for Central Nervous System Cancers 
• NCCN Guidelines Updated for Wilms Tumor 
• NCCN Templates Updated for Colon Cancer and More 
• NCCN Guidelines Updated for Biliary Tract Cancers and Hepatocellular Carcinoma 
• NCCN Guidelines and Templates Updated 

June

• NCCN Guidelines Updated for Neuroendocrine and Adrenal Tumors 
• NCCN Guidelines Updated for Acute Lymphoblastic Leukemia 
• NCCN Templates Updated for Systemic Mastocytosis 
• NCCN Guidelines Updated for Gastric Cancer 

May

• NCCN Guidelines Updated for Prostate Cancer 
• NCCN Guidelines Updated for Pediatric Hodgkin Lymphoma 
• NCCN Guidelines Updated for Bladder Cancer 
• NCCN Guidelines and NCCN Templates Updated for Vulvar Cancer 

April

• NCCN Guidelines Updated for Esophageal and Esophagogastric Junction Cancers 
• NCCN Guidelines Updated for Bladder Cancer 
• NCCN Guidelines Updated for Hepatocellular Carcinoma and Biliary Tract Cancers 
• NCCN Guidelines Updated for Survivorship 
• NEW  NCCN Guidelines for Vaginal Cancer 

March

• NCCN Guidelines Updated for Testicular Cancer 
• NCCN Guidelines Updated for Thyroid Carcinoma 
• NCCN Guidelines Updated for Uterine Neoplasms 
• NCCN Guidelines Updated for Acute Myeloid Leukemia 

February 

• NCCN Guidelines Updated for Palliative Care 
• NCCN Guidelines Updated for Pediatric Acute Lymphoblastic Leukemia 
• NCCN Guidelines Updated for Pediatric Acute Lymphoblastic Leukemia 
• NCCN Guidelines Updated for Thyroid Carcinoma 

January 2024

• NCCN Templates Updated for Castleman Disease and T-Cell Lymphoma 
• NCCN Guidelines Updated for Ovarian Cancer 
• NCCN Templates Updated for Head and Neck Cancers 
• NCCN Guidelines Updated Kidney Cancer 
• NCCN Guidelines Updated for Anal Carcinoma and Small Bowel Adenocarcinoma 

---

---